Literature DB >> 18419457

Association between Vgamma2Vdelta2 T cells and disease progression after infection with closely related strains of HIV in China.

Haishan Li1, Hong Peng, Pengfei Ma, Yuhua Ruan, Bing Su, Xinping Ding, Chen Xu, C David Pauza, Yiming Shao.   

Abstract

BACKGROUND: Human immunodeficiency virus (HIV) infection and disease are accompanied by decreases in the absolute number and function of Vgamma2Vdelta2 T cells, suggesting that this subset of cells may play an important role in controlling disease. We performed a cross-sectional study involving HIV-infected former blood donors and assessed the association between Vgamma2Vdelta2 T cells and markers of disease progression.
METHODS: Changes in Vgamma2Vdelta2 T cell count and function were compared between HIV-infected individuals and healthy blood donors using the Mann-Whitney U test. The relationships between Vgamma2Vdelta2 T cell count, plasma viral load, and CD4 T cell count were analyzed using the Spearman correlation.
RESULTS: We found significant positive correlations between CD4 T cell count and both total Vgamma2Vdelta2 T cell count (P<.001) and functional (isopentenyl pyrophosphate-responsive) Vgamma2Vdelta2 T cell count (P<.001). We found significant reverse correlations between viral load and both total Vgamma2Vdelta2 T cell count (P<.05) and functional Vgamma2Vdelta2 T cell count (P<.05).
CONCLUSIONS: The association of Vgamma2Vdelta2 T cells with disease progression in 146 HIV-infected participants supports the view that intact Vgamma2Vdelta2 T cell populations are important for controlling HIV disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419457      PMCID: PMC2430745          DOI: 10.1086/587107

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  23 in total

Review 1.  Vgamma2Vdelta2+ T cells and anti-microbial immune responses.

Authors:  Zheng W Chen; Norman L Letvin
Journal:  Microbes Infect       Date:  2003-05       Impact factor: 2.700

Review 2.  gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

Authors:  S H Kaufmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

3.  Gamma delta T lymphocyte responses to HIV.

Authors:  M Wallace; S R Bartz; W L Chang; D A Mackenzie; C D Pauza; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

Review 4.  Innate T cell immunity to HIV-infection. Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?

Authors:  M L Gougeon; M Malkovsky; R Casetti; C Agrati; F Poccia
Journal:  Vaccine       Date:  2002-05-06       Impact factor: 3.641

5.  Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

Authors:  Y Tanaka; C T Morita; Y Tanaka; E Nieves; M B Brenner; B R Bloom
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

6.  Early activation of human V gamma 9V delta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands.

Authors:  F Lang; M A Peyrat; P Constant; F Davodeau; J David-Ameline; Y Poquet; H Vié; J J Fournié; M Bonneville
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

7.  Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons.

Authors:  F Poccia; S Boullier; H Lecoeur; M Cochet; Y Poquet; V Colizzi; J J Fournie; M L Gougeon
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

8.  Gamma delta T cells in rhesus monkeys and their response to simian immunodeficiency virus (SIV) infection.

Authors:  Y H Gan; C D Pauza; M Malkovsky
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

9.  Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands.

Authors:  P Constant; F Davodeau; M A Peyrat; Y Poquet; G Puzo; M Bonneville; J J Fournié
Journal:  Science       Date:  1994-04-08       Impact factor: 47.728

10.  T cell receptor gamma/delta+ lymphocyte subsets during HIV infection.

Authors:  B Autran; F Triebel; C Katlama; W Rozenbaum; T Hercend; P Debre
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

View more
  26 in total

1.  Reply to Hartjen et al.

Authors:  Sarah Boudova; Haishan Li; Mohammad M Sajadi; Robert R Redfield; Cristiana Cairo; C David Pauza
Journal:  J Infect Dis       Date:  2013-04-01       Impact factor: 5.226

2.  Interleukin-18 activates Vγ9Vδ2+ T cells from HIV-positive individuals: recovering the response to phosphoantigen.

Authors:  Alanna S Murday; Suchita Chaudhry; C David Pauza
Journal:  Immunology       Date:  2017-05-24       Impact factor: 7.397

Review 3.  HIV infection: focus on the innate immune cells.

Authors:  Milena S Espíndola; Luana S Soares; Leonardo J Galvão-Lima; Fabiana A Zambuzi; Maira C Cacemiro; Verônica S Brauer; Fabiani G Frantz
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

4.  HIV envelope-mediated, CCR5/α4β7-dependent killing of CD4-negative γδ T cells which are lost during progression to AIDS.

Authors:  Haishan Li; C David Pauza
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

5.  The potential role of CD16+ Vγ2Vδ2 T cell-mediated antibody-dependent cell-mediated cytotoxicity in control of HIV type 1 disease.

Authors:  Xuan He; Hua Liang; Kunxue Hong; Haishan Li; Hong Peng; Yangyang Zhao; Manxue Jia; Yuhua Ruan; Yiming Shao
Journal:  AIDS Res Hum Retroviruses       Date:  2013-09-13       Impact factor: 2.205

6.  Impact of persistent HIV replication on CD4 negative Vγ2Vδ2 T cells.

Authors:  Sarah Boudová; Haishan Li; Mohammad M Sajadi; Robert R Redfield; C David Pauza
Journal:  J Infect Dis       Date:  2012-03-26       Impact factor: 5.226

7.  Natural viral suppressors of HIV-1 have a unique capacity to maintain gammadelta T cells.

Authors:  David J Riedel; Mohammad M Sajadi; Cheryl L Armstrong; Jean-Saville Cummings; Cristiana Cairo; Robert R Redfield; C David Pauza
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

Review 8.  Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.

Authors:  Haishan Li; Suchita Chaudhry; Suchita Chaudry; Bhawna Poonia; Yiming Shao; C David Pauza
Journal:  Cell Mol Immunol       Date:  2012-12-17       Impact factor: 11.530

9.  TNF-alpha is a positive regulatory factor for human Vgamma2 Vdelta2 T cells.

Authors:  Haishan Li; Kun Luo; C David Pauza
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

10.  Gammadelta T cell immune manipulation during chronic phase of simian-human immunodeficiency virus infection [corrected] confers immunological benefits.

Authors:  Zahida Ali; Lin Yan; Nicholas Plagman; Armin Reichenberg; Martin Hintz; Hassan Jomaa; Francois Villinger; Zheng W Chen
Journal:  J Immunol       Date:  2009-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.